18 min

Diagnosis and Treatment of Interstitial Lung Disease JAMA Clinical Reviews

    • Medicine

Interstitial lung disease (ILD), characterized by inflammation and fibrosis of the lungs, is associated with progressive dyspnea and results in approximately 25 000 to 30 000 deaths in the US each year. Toby M. Maher, MD, MSc, PhD, of Keck Medicine of USC, discusses the diagnosis and management of ILD with JAMA Deputy Editor Mary McGrae McDermott, MD.

Related Content:
Interstitial Lung Disease

Interstitial lung disease (ILD), characterized by inflammation and fibrosis of the lungs, is associated with progressive dyspnea and results in approximately 25 000 to 30 000 deaths in the US each year. Toby M. Maher, MD, MSc, PhD, of Keck Medicine of USC, discusses the diagnosis and management of ILD with JAMA Deputy Editor Mary McGrae McDermott, MD.

Related Content:
Interstitial Lung Disease

18 min

More by JAMA Network

JAMA Clinical Reviews
JAMA Network
JAMA Medical News
JAMA Network
JAMAevidence JAMA Guide to Statistics and Methods
JAMA Network
JAMA Author Interviews
JAMA Network
JAMA Oncology Author Interviews
JAMA Network
JAMA Cardiology Author Interviews
JAMA Network